Saudi Chemical Holding Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Saudi Chemical Holding.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 14.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case
Mar 06Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors
Feb 10Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return
Oct 31Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today
Jul 06Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50
Jan 09Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50
Dec 22Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital
Sep 14Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around
Dec 06Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?
Apr 19Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital
Mar 29Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?
Mar 01Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?
Feb 01How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?
Dec 28Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?
Nov 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Saudi Chemical Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 4,855 | 183 | 360 | 433 | N/A |
9/30/2023 | 4,521 | 117 | 528 | 598 | N/A |
6/30/2023 | 4,081 | 93 | 492 | 579 | N/A |
3/31/2023 | 3,831 | 80 | 509 | 746 | N/A |
12/31/2022 | 3,696 | 80 | 447 | 707 | N/A |
9/30/2022 | 3,378 | 51 | 102 | 411 | N/A |
6/30/2022 | 3,402 | 48 | -46 | 276 | N/A |
3/31/2022 | 3,346 | 61 | 3 | 190 | N/A |
12/31/2021 | 3,411 | 70 | -179 | 26 | N/A |
9/30/2021 | 3,491 | 53 | -209 | 34 | N/A |
6/30/2021 | 3,517 | 64 | -427 | -189 | N/A |
3/31/2021 | 3,476 | 77 | -284 | 10 | N/A |
12/31/2020 | 3,306 | 74 | -236 | 43 | N/A |
9/30/2020 | 3,066 | 46 | -289 | -39 | N/A |
6/30/2020 | 2,991 | 41 | -31 | 206 | N/A |
3/31/2020 | 2,909 | 32 | -473 | -304 | N/A |
12/31/2019 | 2,949 | 33 | -216 | -54 | N/A |
9/30/2019 | 3,226 | 101 | -148 | -25 | N/A |
6/30/2019 | 3,120 | 101 | -366 | -261 | N/A |
3/31/2019 | 2,998 | 98 | -52 | 55 | N/A |
12/31/2018 | 2,949 | 115 | -161 | -71 | N/A |
9/30/2018 | 2,768 | 128 | -229 | -145 | N/A |
6/30/2018 | 2,650 | 143 | -14 | 97 | N/A |
3/31/2018 | 2,541 | 143 | -79 | 28 | N/A |
12/31/2017 | 2,474 | 142 | 36 | 142 | N/A |
9/30/2017 | 2,274 | 129 | N/A | 223 | N/A |
6/30/2017 | 2,206 | 119 | N/A | -11 | N/A |
3/31/2017 | 2,279 | 138 | N/A | 168 | N/A |
12/31/2016 | 2,143 | 134 | N/A | -9 | N/A |
9/30/2016 | 2,258 | 168 | N/A | -433 | N/A |
6/30/2016 | 2,303 | 185 | N/A | -251 | N/A |
3/31/2016 | 2,320 | 216 | N/A | -433 | N/A |
12/31/2015 | 2,410 | 251 | N/A | -189 | N/A |
9/30/2015 | 2,413 | 266 | N/A | -11 | N/A |
6/30/2015 | 2,452 | 270 | N/A | -5 | N/A |
3/31/2015 | 2,470 | 279 | N/A | 169 | N/A |
12/31/2014 | 2,484 | 284 | N/A | 315 | N/A |
9/30/2014 | 2,566 | 292 | N/A | 303 | N/A |
6/30/2014 | 2,450 | 313 | N/A | 279 | N/A |
3/31/2014 | 2,359 | 303 | N/A | 319 | N/A |
12/31/2013 | 2,275 | 301 | N/A | 111 | N/A |
9/30/2013 | 2,236 | 292 | N/A | 201 | N/A |
6/30/2013 | 2,163 | 282 | N/A | 245 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2230's forecast earnings growth is above the savings rate (14.3%).
Earnings vs Market: Insufficient data to determine if 2230's earnings are forecast to grow faster than the SA market
High Growth Earnings: Insufficient data to determine if 2230's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 2230's revenue is forecast to grow faster than the SA market.
High Growth Revenue: Insufficient data to determine if 2230's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2230's Return on Equity is forecast to be high in 3 years time